Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Ayala Pharmaceuticals (AYLA)

Ayala Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AYLA
DateTimeSourceHeadlineSymbolCompany
08/02/202322:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AYLAAyala Pharmaceuticals Inc
06/02/202319:50Edgar (US Regulatory)Schedule 13g
(sc 13g/a)
NASDAQ:AYLAAyala Pharmaceuticals Inc
25/01/202321:54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202315:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202311:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AYLAAyala Pharmaceuticals Inc
24/01/202311:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202320:52Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202320:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202320:43Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/01/202320:33Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AYLAAyala Pharmaceuticals Inc
13/01/202321:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
04/01/202322:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
23/11/202221:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
17/11/202221:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
04/11/202220:38Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:AYLAAyala Pharmaceuticals Inc
03/11/202220:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/10/202221:11Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:AYLAAyala Pharmaceuticals Inc
19/10/202221:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
11/10/202208:46TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
11/10/202208:45TipRanksNoble Financial Reaffirms Their Hold Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
27/09/202214:11TipRanksAyala Pharma (NASDAQ:AYLA) Bags fast Track Status for Desmoid Tumor CandidateNASDAQ:AYLAAyala Pharmaceuticals Inc
27/09/202212:58Dow Jones NewsAyala Pharmaceuticals Gets Fast-Track Designation for AL102 Cancer TreatmentNASDAQ:AYLAAyala Pharmaceuticals Inc
19/09/202210:25TipRanksH.C. Wainwright Sticks to Their Buy Rating for Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
13/09/202212:05TipRanksAyala Pharmaceuticals (AYLA) Receives a Buy from Noble FinancialNASDAQ:AYLAAyala Pharmaceuticals Inc
12/09/202212:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYLAAyala Pharmaceuticals Inc
17/08/202212:05TipRanksNoble Financial Keeps Their Buy Rating on Ayala Pharmaceuticals (AYLA)NASDAQ:AYLAAyala Pharmaceuticals Inc
16/08/202220:40AllPennyStocks.comQ2 Financial Results Send Micro Cap SoaringNASDAQ:AYLAAyala Pharmaceuticals Inc
15/08/202220:21Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AYLAAyala Pharmaceuticals Inc
27/07/202212:25TipRanksNoble Financial Thinks Ayala Pharmaceuticals’ Stock is Going to RecoverNASDAQ:AYLAAyala Pharmaceuticals Inc
26/07/202218:24TipRanksAyala Pharmaceuticals Stock Nearly Triples on Desmoid Tumor Treatment NewsNASDAQ:AYLAAyala Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AYLA